Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CliniTrial

Financiado

Cerrado

Enhancement of an advanced clinical trial recruitment platform for Europe to ens...

Enhancement of an advanced clinical trial recruitment platform for Europe to ensure maximum intake of eligible consenting patients for participation Many patients can’t effectively be treated with the standard of care today. They suffer from their diseases that can’t be managed or cured. Newly developed therapies represent their only hope. Unfortunately, it takes ever more tim... ver más

30/04/2017

viomedo

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

VIOMEDO UG HAFTUNGSBESCHRANKT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-04-30

SMEInst-06-2016-2017: Accelerating market introduction of...

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

viomedo

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Trials@Home Trials@Home Center of Excellence Remote Decentralised Cli... 38M€ Cerrado

PATIENTPARTNER Identifying the Needs for Patients Partnering in Clinical Re... 1M€ Cerrado

QRD A uniQue platform enabling faster development of treatments... 71K€ Cerrado

REPO-TRIAL An in silico based approach to improve the efficacy and prec... 6M€ Cerrado

EU-PEARL EU Patient cEntric clinicAl tRial pLatform 26M€ Cerrado

SEMCARE Semantic Data Platform for Healthcare 2M€ Cerrado

Duración del proyecto: 5 meses Fecha Inicio: 2016-11-23
Fecha Fin: 2017-04-30

Líder del proyecto

VIOMEDO UG HAFTUNGSBESCHRANKT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Many patients can’t effectively be treated with the standard of care today. They suffer from their diseases that can’t be managed or cured. Newly developed therapies represent their only hope. Unfortunately, it takes ever more time and money to bring innovative therapies to market. A major challenge in clinical development is finding the right patients to participate in clinical trials. The problem is that patients lack access to trials. The online platform viomedo supports patients with finding the right clinical trial for them, while helping the organizations that run trials, such as pharmaceutical companies, recruit patients more efficiently. The disruptive solution provides access to over 2.000 up-to-date clinical trials that are recruiting patients in Germany. Patients, care givers or doctors can easily search for a trial by disease, confirm their eligibility and contact the investigator. Patients want to be increasingly involved in deciding which therapy to choose. 75% of them are interested in learning about clinical trial opportunities. Most turn mainly to the internet for health-related information. However, a patient-centric online platform for clinical trials is missing. Viomedo empowers patients by providing this platform. Important milestones – such as the development of a public beta version of the platform, collaboration with leading patient advocacy groups, acquisition of six large pilots with pharmaceutical companies – have been reached. The goal of phase 1 is to complete the pilot projects and develop an EU-wide rollout strategy. After the business case is ready and validated, viomedo will be rolled out to major European markets in phase 2. Once viomedo is rolled out to all European patients, it will help more patients benefit from the research earlier. It will also make the EU a more attractive region for conducting research. It will help bring patient centricity and openness into the industry, raising the quality of clinical research conducted.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores